Early research (Phase 1)Study completedNCT02585440
What this trial is testing
A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects
Who this might be right for
Infectious Disease
ContraVir Pharmaceuticals, Inc. 50
Showing 20 of 0 results